Overview of treatment strategies in paraneoplastic neurological syndromes.
Cerebellar degeneration
Cyclophosphamide
Encephalitis
Immunotherapy
Intravenous immunoglobulins
Lambert-Eaton myasthenic syndrome
Neuronopathy
Opsoclonus-myoclonus
Paraneoplastic neurological syndrome
Plasma exchange
Rituximab
Stiff-person syndrome
Tumor treatment
Journal
Handbook of clinical neurology
ISSN: 0072-9752
Titre abrégé: Handb Clin Neurol
Pays: Netherlands
ID NLM: 0166161
Informations de publication
Date de publication:
2024
2024
Historique:
medline:
18
3
2024
pubmed:
18
3
2024
entrez:
17
3
2024
Statut:
ppublish
Résumé
Treatment strategies in paraneoplastic neurological syndromes rely on the three pillars of tumor treatment, immunotherapy, and symptomatic treatment, the first one being by far the most important in the majority of patients and syndromes. Classically, antibodies against extracellular antigens are directly pathogenic, and patients with these syndromes are more responsive to immunomodulatory or immunosuppressive treatments than the ones with antibodies against intracellular targets. This chapter first discusses some general principles of tumor treatment and immunotherapy, followed by a closer look at specific treatment options for different clinical syndromes, focusing on symptomatic treatments.
Identifiants
pubmed: 38494299
pii: B978-0-12-823912-4.00015-3
doi: 10.1016/B978-0-12-823912-4.00015-3
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
97-112Informations de copyright
Copyright © 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.